Surgical robot technology developer CMR Surgical announced today that it appointed Supratim Bose as its new CEO.
Bose takes over from Per Vegard Nerseth with immediate effect. He joined the company last month as a senior advisor to the CEO. Bose also took over leadership of the Asia, Middle East and Africa regions, leading commercial operations in those geographies.
With more than 40 years in the medtech industry, Bose held multiple leadership positions at global organizations. Those include Johnson & Johnson, Boston Scientific and ConvaTec, according to a news release. His appointment comes as CMR Surgical aims to continue commercializing its business. It already has more than 100 Versius surgical robot systems installed globally.
“With Versius we have an opportunity to help hospitals and surgeons transform surgery for people around the world,” Bose said. “I am excited to lead a business that has such a differentiated product with Versius, that is addressing a high unmet need for better surgical care around the world. I look forward to working with everyone at CMR to bring the benefits of surgical robotics to hospitals and surgeons around the world.”
About CMR Surgical and the Versius platform
CMR Surgical was included on our list of surgical robotics companies you need to know.
The Versius robotic surgery system is used by surgeons across Europe, the Middle East, Asia, Australia & Latin America. CMR announced the completion of 5,000 surgeries around the world in 2022. In June 2021, the surgical robotics developer raised $600 million in a Series D financing round. In November, the company partnered with Johnson & Johnson’s Ethicon to sell Versius in select markets.
CMR Surgical designed Versius to enable surgeons to perform more minimal access surgery. The company says this offers patients “access to the highest quality of surgical care.”
Versius features freedom of port placement. This best suits the needs of each patient, allowing surgeons to operate the way they did laparoscopically, but with the benefits of robotic surgery, according to the company. It has a small, lightweight and modular design that can be moved “effortlessly.”
Versius’ small-scale design — enabled by v-wrist technology — optimizes it for any virtually any OR, according to CMR Surgical. Its collaborative arms and bedside units can be set up and adjusted to provide direct access to the patient. The system includes a suite of fully wristed instruments and enhanced 3D HD vision.
“During my time at the company I am proud to have seen CMR expand its commercial operations and bring Versius into the hands of more surgeons and hospitals,” said Per Vegard Nerseth. “After experiencing strong growth, CMR is now the second-largest surgical robotics company on the market with a significant presence across four continents. I look forward to seeing the Company continue to grow so that more hospitals and patients can benefit from minimal access surgery.”